Burashnikov A et al: Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure. Circ Heart Fail 2014;7:627.
Carmichael P, Lieben J: Sudden death in explosives workers. Arch Environ Health 1963;7:50.
Catterall WA, Swanson TM: Structural basis for pharmacology of voltage-gated sodium and calcium channels. Mol Pharmacol 2015;88:141.
Chaitman BR et al: Effects of ranolazine, with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. A randomized controlled trial. JAMA 2004;291:309.
Chang C-R, Sallustio B, Horowitz JD: Drugs that affect cardiac metabolism: Focus on perhexiline. Cardiovasc Drugs Ther 2016;30:399.
Chen JF, Eltschig HK, Fredholm BB: Adenosine receptors as targets—What are the challenges? Nat Rev Drug Discov 2013;12:265.
Chen Z, Zhang J, Stamler JS: Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci 2002;99:8306.
Cooper-DeHoff RM, Chang S-W, Pepine CJ: Calcium antagonists in the treatment of coronary artery disease. Curr Opin Pharmacol 2013;13:301.
DeWitt CR, Waksman JC: Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 2004;23:223.
Fihn SD et al: Guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary. Circulation 2012;126:3097.
Fraker TD Jr, Fihn SD: 2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007;50:2264.
Goldman L et al: Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale. Circulation 1981;64:1227.
Husted SE, Ohman EM: Pharmacological and emerging therapies in the treatment of chronic angina. Lancet 2015;386:691.
Ignarro LJ et al: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739.
Kannam JP, Aroesty JM, Gersh BJ: Overview of the management of stable angina pectoris. UpToDate, 2016. http://www.uptodate.com.
Kast R et al: Cardiovascular effects of a novel potent and highly selective asaindolebased inhibitor of Rho-kinase. Br J Pharmacol 2007;152:1070.
Lacinova L: Voltage-dependent calcium channels. Gen Physiol Biophys 2005;24(Suppl 1):1.
Li H, Föstermann U: Uncoupling of endothelial NO synthesis in atherosclerosis and vascular disease. Curr Opin Pharmacol 2013;13:161.